NANOVIRICIDES, INC. Net Fee Amt
NANOVIRICIDES, INC. (NNVC) had Net Fee Amt of $608.14 as of 2026-08-21, per its S-3 filed 2026-08-21.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-21
- 2026-08-21: Net Fee Amt $608.14.
- 2026-06-09: Net Fee Amt $322.23.
- 2026-06-01: Net Fee Amt $6.91K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-21 | $608.14 S-3 · filed 2026-08-21 |
| 2026-06-09 | $322.23 S-3 · filed 2026-06-15 |
| 2026-06-01 | $6.91K S-3 · filed 2026-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |